Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Unaudited)

v3.24.1.1.u2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock, Common [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Unallocated Common Share Held By ESOP [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock Outstanding [Member]
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Unallocated Common Share Held By ESOP [Member]
Total
Balance (in shares) at Dec. 31, 2022               5,397,959              
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022 $ 0 $ 0 $ 0 $ (279) $ 0 $ 0 $ (279)                
Balance at Dec. 31, 2022                 $ 54 $ 0 $ 50,420 $ 45,291 $ (11,125) $ (4,098) $ 80,542
Net income (losses)                 0 0 0 170 0 0 170
ESOP shares committed to be released                 0 0 1 0 0 54 55
Change in net unrealized loss on securities available for sale, net                 0 0 0 0 1,581 0 1,581
Balance (in shares) at Mar. 31, 2023               5,397,959              
Balance at Mar. 31, 2023                 54 0 50,421 45,182 (9,544) (4,044) 82,069
Balance (in shares) at Dec. 31, 2023               5,315,261              
Balance at Dec. 31, 2023                 56 (2,381) 50,920 41,055 (8,223) (3,882) 77,545
Net income (losses)                 0 0 0 (246) 0 0 (246)
ESOP shares committed to be released                 0 0 (2) 0 0 53 51
Change in net unrealized loss on securities available for sale, net                 0 0 0 0 (550) 0 (550)
Stock based compensation                 0 0 162 0 0 0 162
Balance (in shares) at Mar. 31, 2024               5,315,261              
Balance at Mar. 31, 2024                 $ 56 $ (2,381) $ 51,080 $ 40,809 $ (8,773) $ (3,829) $ 76,962